Quick and comprehensive information on psychotropic drugs for adults.Accurate and up-to-date – now with esketamine (Spravato)Comparison charts help decision-makingIcons and full colorAvailable in print and onlineDownloadable patient info sheetsThe Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.Independent, unbiased, up-to-datePacked with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions ) for a quick overview of treatment optionsSuccinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more all you need to know for each class of drugPotential interactions and side effects summarized in comparison chartsWith instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seekClearly written patient information sheets available for download as printable PDF filesNew in this edition:Antidepressants chapter includes new section on esketamine (Spravato), recently approved for treatment-resistant depression; also updates to antidepressant use in pregnancy and SPARI drug interactionsAntipsychotics updates include new section on 5-HT2A inverse agonist antipsychotic (pimavanserin, Nuplazid) and comprehensive revision of augmentation strategiesPharmacogenomics chapter fully revised with expanded dose adjustment recommendationsChart of agents under investigation for treatment of substance use disorders fully revised, new agents include lofexidine (Lucemyra), Kadian, nortriptyline e-cigarettesUnapproved treatments chapter with significant updates, including new sections on adrenergic agents in PTSD (doxazosin), antiflammatory agents in depression (pioglitazone, rosiglitazone, statins), and hormones in schizophrenia (raloxifene)Expanded treatment options for extrapyramidal side effects include deutetrabenazine and valbenazineNew formulations and trade names include: Spravato (esketamine), as well as Adzenys ER, Aristada, Austedo, Cotempla XR-ODT, Fanatrex FusePaq, Foquest, Ingrezza, Jornay PM, Mydayis, Nuplazid, Sublocade, ZelaparThis book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.
